358 related articles for article (PubMed ID: 19382992)
1. Autoimmune polyendocrine syndrome type 1 (APS-1) as a model for understanding autoimmune polyendocrine syndrome type 2 (APS-2).
Michels AW; Eisenbarth GS
J Intern Med; 2009 May; 265(5):530-40. PubMed ID: 19382992
[TBL] [Abstract][Full Text] [Related]
2. Introduction: Autoimmune polyendocrine syndrome type 1 (APS-1): a rare monogenic disorder as a model to improve understanding of tolerance and autoimmunity.
Kämpe O
J Intern Med; 2009 May; 265(5):511-3. PubMed ID: 19382990
[No Abstract] [Full Text] [Related]
3. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I.
Husebye ES; Perheentupa J; Rautemaa R; Kämpe O
J Intern Med; 2009 May; 265(5):514-29. PubMed ID: 19382991
[TBL] [Abstract][Full Text] [Related]
4. Genetic dissection of autoimmune polyendocrine syndrome type 2: common origin of a spectrum of phenotypes.
Ballarini A; Lee-Kirsch MA
Ann N Y Acad Sci; 2007 Sep; 1110():159-65. PubMed ID: 17911431
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene.
Wolff AS; Erichsen MM; Meager A; Magitta NF; Myhre AG; Bollerslev J; Fougner KJ; Lima K; Knappskog PM; Husebye ES
J Clin Endocrinol Metab; 2007 Feb; 92(2):595-603. PubMed ID: 17118990
[TBL] [Abstract][Full Text] [Related]
6. [Seric 21-hydroxilase antibodies in patients with anti-microsomal fraction antibodies. Autoimmune polyendocrine syndrome].
Botta S; Roveto S; Rimoldi D
Medicina (B Aires); 2007; 67(2):143-6. PubMed ID: 17593598
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I.
Oftedal BE; Wolff AS; Bratland E; Kämpe O; Perheentupa J; Myhre AG; Meager A; Purushothaman R; Ten S; Husebye ES
Clin Immunol; 2008 Oct; 129(1):163-9. PubMed ID: 18708298
[TBL] [Abstract][Full Text] [Related]
8. [Autoimmune polyendocrine syndromes and related diseases: pathogenesis and clinical features].
Igaz P; Rácz K; Tulassay Z
Orv Hetil; 2005 Jul; 146(29):1531-7. PubMed ID: 16136774
[TBL] [Abstract][Full Text] [Related]
9. [Autoimmune polyendocrine syndrome type 2 associated with autoimmune hypophysitis and coeliac disease].
Hrubisková K; Jackuliak P; Vanuga P; Pura M; Payer J
Vnitr Lek; 2010 Nov; 56(11):1169-76. PubMed ID: 21250496
[TBL] [Abstract][Full Text] [Related]
10. [Type 2 autoimmune polyendocrine syndromes (APS-2)].
Vialettes B; Dubois-Leonardon N
Bull Acad Natl Med; 2013 Jan; 197(1):31-40; discussion 40-1. PubMed ID: 24672978
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP-Seq.
Vazquez SE; Ferré EM; Scheel DW; Sunshine S; Miao B; Mandel-Brehm C; Quandt Z; Chan AY; Cheng M; German M; Lionakis M; DeRisi JL; Anderson MS
Elife; 2020 May; 9():. PubMed ID: 32410729
[TBL] [Abstract][Full Text] [Related]
12. Update on autoimmune polyendocrine syndromes (APS).
Betterle C; Zanchetta R
Acta Biomed; 2003 Apr; 74(1):9-33. PubMed ID: 12817789
[TBL] [Abstract][Full Text] [Related]
13. Mathematical analysis of clinical data reveals a homunculus of bacterial mimotopes protecting from autoimmunity via oral tolerance in human.
Kristóf K; Madách K; Czaller I; Bajtay Z; Erdei A
Mol Immunol; 2009 May; 46(8-9):1673-8. PubMed ID: 19286262
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease.
F Magitta N; Pura M; S Bøe Wolff A; Vanuga P; Meager A; M Knappskog P; Husebye ES
Eur J Endocrinol; 2008 May; 158(5):705-9. PubMed ID: 18426830
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I.
Wolff AS; Oftedal BE; Kisand K; Ersvaer E; Lima K; Husebye ES
Scand J Immunol; 2010 Jun; 71(6):459-67. PubMed ID: 20500699
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.
Meloni A; Furcas M; Cetani F; Marcocci C; Falorni A; Perniola R; Pura M; Bøe Wolff AS; Husebye ES; Lilic D; Ryan KR; Gennery AR; Cant AJ; Abinun M; Spickett GP; Arkwright PD; Denning D; Costigan C; Dominguez M; McConnell V; Willcox N; Meager A
J Clin Endocrinol Metab; 2008 Nov; 93(11):4389-97. PubMed ID: 18728167
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune polyglandular syndromes: interplay between the immune and the endocrine systems leading to a diverse set of clinical diseases and new insights into immune regulation.
Lebovitz HE
Diabetes Technol Ther; 2013 Jun; 15 Suppl 2():S2-21-S2-28. PubMed ID: 23786295
[TBL] [Abstract][Full Text] [Related]
18. Serological proteome analysis reveals new specific biases in the IgM and IgG autoantibody repertoires in autoimmune polyendocrine syndrome type 1.
Dubucquoi S; Proust-Lemoine E; Kemp EH; Ryndak A; Lefèvre-Dutoit V; Bellart M; Saugier-Véber P; Duban-Deweer S; Wémeau JL; Prin L; Lefranc D
Autoimmunity; 2015; 48(8):532-41. PubMed ID: 26312540
[TBL] [Abstract][Full Text] [Related]
19. Clearing the AIRE: on the pathophysiological basis of the autoimmune polyendocrinopathy syndrome type-1.
Shikama N; Nusspaumer G; Holländer GA
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):273-88, vii. PubMed ID: 19328411
[TBL] [Abstract][Full Text] [Related]
20. Epitope mapping of human aromatic L-amino acid decarboxylase.
Bratland E; Wolff AS; Haavik J; Kämpe O; Sköldberg F; Perheentupa J; Bredholt G; Knappskog PM; Husebye ES
Biochem Biophys Res Commun; 2007 Feb; 353(3):692-8. PubMed ID: 17194446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
